https://www.nobomedicine.com/publication/a-clinical-decision-support-tool-for-differential-diagnosis-of-tma-with-enhanced-accuracy-using-an-ensemble-method/2024-04-08T09:21:43+09:00https://www.nobomedicine.com/publication/the-molecular-pathogenesis-of-trichilemmal-carcinoma/2024-04-08T09:21:02+09:00https://www.nobomedicine.com/publication/direct-haplotyping-based-noninvasive-prenatal-test-for-myotonic-dystrophy-type-1-with-large-ctg-expansion/2024-04-08T09:20:12+09:00https://www.nobomedicine.com/publication/npm1-as-a-potential-therapeutic-target-for-atypical-teratoid-rhabdoid-tumors/2024-04-08T09:19:37+09:00https://www.nobomedicine.com/publication/rtk-ras-pathway-mutation-is-enriched-in-myeloid-sarcoma-blood-cancer-journal/2024-04-08T09:18:43+09:00https://www.nobomedicine.com/publication/noninvasive-prenatal-test-of-single-gene-disorders-by-linked-readdirect-haplotyping-application-in-various-diseases/2024-04-08T09:18:09+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-is-associated-with-risk-of-severe-covid-19-2/2024-04-08T09:17:39+09:00https://www.nobomedicine.com/publication/prediction-of-incident-atherosclerotic-cardiovascular-disease-with-polygenic-risk-of-metabolic-disease-analysis-of-3-prospective-cohort-studies-in-korea/2024-04-08T09:22:44+09:00https://www.nobomedicine.com/publication/the-presence-of-clonal-hematopoiesis-is-negatively-associated-with-diabetic-peripheral-neuropathy-in-type-2-diabetes/2024-04-08T09:17:10+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-with-dnmt3a-mutation-is-associated-with-lower-white-matter-hyperintensity-volume/2024-04-08T09:16:26+09:00https://www.nobomedicine.com/publication/interplay-between-chronic-inflammation-and-clonal-haematopoiesis-of-indeterminate-potential-in-behcets-disease/2024-04-08T09:15:43+09:00https://www.nobomedicine.com/publication/clinical-impact-of-clonal-hematopoiesis-on-severe-covid-19-patients-without-canonical-risk-factors/2024-04-08T09:15:13+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-as-a-novel-risk-factor-for-type-2-diabetes-mellitus-in-patients-with-hypercholesterolemia/2024-04-08T09:14:34+09:00https://www.nobomedicine.com/publication/pre-operative-clonal-hematopoiesis-is-related-to-adverse-outcome-in-lung-cancer-after-adjuvant-therapy/2024-04-08T09:13:54+09:00https://www.nobomedicine.com/publication/clonal-haematopoiesis-of-indeterminate-potential-and-atrial-fibrillation-an-east-asian-cohort-study/2024-04-08T09:13:27+09:00https://www.nobomedicine.com/publication/impact-of-clonal-haematopoiesis-on-atherosclerotic-cardiovascular-disease-according-to-low-density-lipoprotein-cholesterol-levels-in-general-population/2024-04-08T09:12:42+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-and-acute-ischemic-stroke-outcomes/2024-04-08T09:09:34+09:00https://www.nobomedicine.com/publication/combination-of-acalabrutinib-with-lenalidomide-and-rituximab-in-relapsed-refractory-aggressive-b-cell-non-hodgkin-lymphoma-a-single-arm-phase-ii-trial/2024-04-08T08:51:10+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-in-lgi1-antibody-encephalitis/2024-08-29T15:34:36+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-with-dnmt3a-mutations-is-associated-with-multiple-system-atrophy/2024-09-19T09:14:40+09:00https://www.nobomedicine.com/publication/parkinsons-disease-is-associated-with-clonal-hematopoiesis-with-tet2-mutation/2024-10-21T18:17:41+09:00https://www.nobomedicine.com/publication/machine-learning-based-predictive-classifier-for-bone-marrow-failure-syndrome-using-complete-blood-count-data/2024-10-21T18:32:05+09:00https://www.nobomedicine.com/publication/influence-of-the-bone-marrow-microenvironment-on-hematopoietic-stem-cell-behavior-post-allogeneic-transplantation-development-of-clonal-hematopoiesis-and-telomere-dynamics/2024-10-21T18:31:33+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-of-indeterminate-potential-is-associated-with-current-smoking-status-and-history-of-exacerbation-in-patients-with-chronic-obstructive-pulmonary-disease/2024-10-21T18:35:27+09:00https://www.nobomedicine.com/publication/consistent-count-region-copy-number-variation-ccr-cnv-an-expandable-and-robust-tool-for-clinical-diagnosis-of-copy-number-variation-at-the-exon-level-using-next-generation-sequencing-data/2024-10-21T18:38:13+09:00https://www.nobomedicine.com/publication/genetic-regulation-of-oas1-nonsense-mediated-decay-underlies-association-with-covid-19-hospitalization-in-patients-of-european-and-african-ancestries/2024-10-21T18:41:44+09:00https://www.nobomedicine.com/publication/phase-ii-study-of-glofitamab-poseltinib-and-lenalidomide-in-patients-with-relapsed-refractory-diffuse-b-cell-lymphomas/2024-12-23T18:06:50+09:00https://www.nobomedicine.com/publication/glofitamab-combined-with-poseltinib-and-lenalidomide-for-relapsed-refractory-diffuse-large-b-cell-lymphoma-interim-analysis-of-gpl-study/2024-12-23T18:06:17+09:00https://www.nobomedicine.com/publication/increased-local-dna-methylation-disorder-in-amls-with-dnmt3a-destabilizing-variants-and-its-clinical-implication/2025-01-14T11:11:11+09:00https://www.nobomedicine.com/publication/association-of-clonal-hematopoiesis-of-indeterminate-potential-with-myocardial-characteristic-differences-in-non-ischemic-heart-failure/2025-02-26T09:22:44+09:00https://www.nobomedicine.com/publication/chemotherapy-free-salvage-therapy-with-rituximab-lenalidomide-and-poseltinib-in-relapsed-or-refractory-primary-central-nervous-system-lymphoma-a-multi-center-phase-ii-study/2026-01-19T13:21:23+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-and-risk-of-trastuzumab-related-cardiotoxic-effects/2026-04-08T13:54:35+09:00https://www.nobomedicine.com/publication/clonal-hematopoiesis-of-indeterminate-potential-and-kidney-failure-in-ckd-an-east-asian-cohort-study/2026-08-28T10:03:03+09:00https://www.nobomedicine.com/publication/clonal-haematopoiesis-of-indeterminate-potential-a-risk-factor-for-future-exacerbation-in-patients-with-copd/2026-08-28T10:11:13+09:00https://www.nobomedicine.com/publication/single-cell-transcriptome-analyses-reveal-distinct-gene-expression-signatures-of-severe-covid-19-in-the-presence-of-clonal-hematopoiesis/2026-08-28T10:23:14+09:00